Archit Organosys Ltd
Archit Organosys Ltd (ARCHITORG) last reported results for the quarter ended Mar 2024, with sales of ₹30.99 crore and net profit of ₹1.79 crore. The stock last traded at ₹60.2, a market capitalisation of ₹124 crore, on a P/E of 309. Over the past 52 weeks the stock has ranged between ₹34 and ₹72. Figures are as of 6 Oct 2026 and are not real time.
Archit Organosys Ltd share price and key metrics
- Current price
- ₹60.2
- Market cap
- ₹124 cr
- Stock P/E
- 309
- Book value
- ₹31.3
- ROE
- 0.64%
- ROCE
- 3.60%
- Dividend yield
- 1.67%
- 52w high / low
- 72.0/34.0
Metrics as of 6 Oct 2026. Not real time.
Track Archit Organosys Ltd
Cruxal reads every Archit Organosys Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Archit Organosys Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -11%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -96%
- 10 Years
- 11%
- 5 Years
- 4%
- 3 Years
- 2%
- 1 Year
- 33%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 11%
- Last Year
- 1%
Archit Organosys Ltd quarterly results
In the quarter ended Mar 2024, sales were ₹30.99 cr, down 33.4% from ₹46.55 cr a year earlier. Net profit was ₹1.79 cr, down 7.7% year on year.
| ₹ crore | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Sales | 30.35 | 28.46 | 22.42 | 46.55 | 31 | 26.39 | 24.81 | 30.99 |
| Expenses | 23.18 | 23.22 | 18.84 | 43.64 | 27.75 | 24.28 | 23.71 | 31.16 |
| Operating profit | 7.17 | 5.24 | 3.58 | 2.91 | 3.25 | 2.11 | 1.1 | -0.17 |
| OPM % | 23.62% | 18.41% | 15.97% | 6.25% | 10.48% | 8.00% | 4.43% | -0.55% |
| Other income | 0.21 | 0.16 | 1.84 | 1.29 | 0.64 | 0.54 | 0.52 | 4.11 |
| Interest | 0.86 | 0.32 | 0.52 | 0.51 | 0.52 | 0.65 | 0.77 | 0.64 |
| Depreciation | 1.2 | 1.17 | 1.31 | 1.16 | 1.19 | 1.49 | 1.49 | 1.02 |
| Profit before tax | 5.32 | 3.91 | 3.59 | 2.53 | 2.18 | 0.51 | -0.64 | 2.28 |
| Tax % | 22.56% | 21.74% | 37.88% | 23.32% | 27.52% | 27.45% | -29.69% | 21.49% |
| Net profit | 4.12 | 3.06 | 2.23 | 1.94 | 1.57 | 0.37 | -0.46 | 1.79 |
| EPS (₹) | 2.01 | 1.49 | 1.09 | 0.95 | 0.77 | 0.18 | -0.22 | 0.87 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Archit Organosys Ltd annual results
| ₹ crore | Mar 2007 | Mar 2008 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Sales | 19 | 21 | 138 | 128 | 113 |
| Operating profit | 1 | 1 | 17 | 20 | 7 |
| OPM % | 3.6% | 4.1% | 12% | 15% | 6% |
| Net profit | 0 | 0 | 8 | 11 | 3 |
| EPS (₹) | 0.39 | 0.41 | 4.01 | 5.53 | 1.60 |
TTM is the trailing twelve months to the most recent quarter.
Archit Organosys Ltd balance sheet
| ₹ crore | Mar 2007 | Mar 2008 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Equity capital | 3 | 3 | 21 | 21 | 21 |
| Reserves | -0 | 0 | 31 | 41 | 44 |
| Borrowings | 4 | 7 | 34 | 31 | 26 |
| Other liabilities | 3 | 3 | 18 | 27 | 18 |
| Total liabilities | 10 | 13 | 104 | 120 | 108 |
| Fixed assets | 3 | 3 | 45 | 50 | 60 |
| CWIP | 0 | 0 | 13 | 16 | 1 |
| Investments | 0 | 0 | 1 | 4 | 6 |
| Other assets | 7 | 10 | 44 | 50 | 42 |
| Total assets | 10 | 13 | 104 | 120 | 108 |
As reported by the company. Total assets equal total liabilities by construction.
Archit Organosys Ltd cash flow
| ₹ crore | Mar 2007 | Mar 2008 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Cash from operations | 1 | -2 | 11 | 17 | 10 |
| Cash from investing | -0 | -0 | -12 | -11 | -2 |
| Cash from financing | -1 | 3 | 2 | -7 | -9 |
| Net cash flow | 0 | 0 | 2 | -0 | -1 |
| Free cash flow | 1 | -2 | -0 | 6 | 15 |
| CFO / operating profit | 181% | -213% | 73% | 105% | 162% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Archit Organosys Ltd operating ratios
| Per year | Mar 2007 | Mar 2008 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|
| ROCE % | — | 15% | — | 18% | 4% |
| Debtor days | 99 | 103 | 72 | 107 | 72 |
| Inventory days | 22 | 42 | 22 | 16 | 16 |
| Days payable | 81 | 58 | 51 | 110 | 63 |
| Cash conversion cycle | 40 | 88 | 44 | 13 | 25 |
| Working capital days | 72 | 119 | -0 | 2 | 10 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Archit Organosys Ltd shareholding pattern
Promoters held 65.88% at Jun 2026, broadly unchanged since Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 64.65% | 64.84% | 65.30% | 65.39% | 65.39% | 65.86% | 65.88% | 65.88% |
| Public | 35.35% | 35.15% | 34.70% | 34.61% | 34.60% | 34.15% | 34.12% | 34.11% |
| No. of shareholders | 10,389 | 10,198 | 9,972 | 9,947 | 9,847 | 9,630 | 9,446 | 8,959 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Archit Organosys Ltd corporate filings
- Company holds AGM with all resolutions passed; significant shareholder voting activity notedAGM/EGMhigh impact
Cruxal's analysis: Archit Organosys Limited conducted its 33rd Annual General Meeting on September 30, 2026…
Read the full analysis - Archit Organosys Limited holds 33rd AGM; no financial results or strategic updates disclosedAGM/EGMlow impact
Cruxal's analysis: Archit Organosys Limited conducted its 33rd Annual General Meeting on 30th September 2026…
Read the full analysis - Archit Organosys Ltd publishes corrigendum to 33rd Annual General Meeting noticeCompany Updatelow impact
Cruxal's analysis: Archit Organosys Ltd has issued a corrigendum regarding the notice for its 33rd Annual…
Read the full analysis - Archit Organosys Ltd issues corrigendum to FY 2025-26 Annual ReportOtherslow impact
Cruxal's analysis: Archit Organosys Ltd has released a corrigendum regarding its Annual Report for the…
Read the full analysis - Archit Organosys Limited Withdraws Key Agenda Items from Upcoming AGMAGM/EGMhigh impact
Cruxal's analysis: Archit Organosys Limited has issued a corrigendum to its Annual General Meeting notice…
Read the full analysis - Archit Organosys Limited withdraws proposed acquisition of Archit Life Science Limited and preferential share issueOthersmedium impact
Cruxal's analysis: Archit Organosys Limited has announced the withdrawal of three key agenda items from its…
Read the full analysis - Archit Organosys Ltd announces newspaper publication for 33rd Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Archit Organosys Ltd has submitted the required newspaper advertisement regarding the…
Read the full analysis - Archit Organosys Limited Announces 33rd AGM, Preferential Issue of 3.72 Crore Shares, and Acquisition of Archit Life Science LimitedAGM/EGMhigh impact
Cruxal's analysis: Archit Organosys Limited has announced its 33rd Annual General Meeting to be held on 30th…
Read the full analysis - Archit Organosys Ltd files Annual Report for F.Y. 2025-26Otherslow impact
Cruxal's analysis: Archit Organosys Ltd has submitted its Annual Report for the financial year 2025-26 as…
Read the full analysis - Archit Organosys Limited announces record date of 23rd September 2026 for final dividend paymentCorp. Actionlow impact
Cruxal's analysis: Archit Organosys Limited has formally notified the BSE of the record date set for 23rd…
Read the full analysis - Archit Organosys Limited Announces Strategic Acquisition of Archit Life Science Limited via Share SwapBoard Meetinghigh impact
Cruxal's analysis: Archit Organosys Limited has approved a preferential issue of 3.72 crore equity shares at…
Read the full analysis - Closure of trading window on account of Board meeting scheduled on 03.09.2026Insider Trading / SASTlow impact
- Archit Organosys Limited announces board meeting to evaluate fund-raising proposal via preferential issueBoard Meetinghigh impact
Cruxal's analysis: Archit Organosys Limited has scheduled a board meeting for 3rd September 2026 to consider…
Read the full analysis - Archit Organosys Limited announces Q1 FY27 financial results and physical share transfer windowCompany Updatelow impact
Cruxal's analysis: Archit Organosys Limited has released its unaudited financial results for the quarter…
Read the full analysis - Archit Organosys Limited reports Q1 FY2027 financial results with net profit of 1.45 croreBoard Meetingmedium impact
Cruxal's analysis: Archit Organosys Limited reported revenue from operations of 37.08 crore for the quarter…
Read the full analysis - Archit Organosys Limited schedules Board Meeting for August 12, 2026, to approve Q1 FY27 financial resultsBoard Meetinglow impact
Cruxal's analysis: Archit Organosys Limited has formally intimated the BSE regarding a Board of Directors…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.